A Phase I/II Trial Evaluating the Combination of Arsenic Trioxide, Bortezomib and Ascorbic Acid for Patients with Relapsed or Refractory Multiple Myeloma.James R. Berenson, Sal Bevivino, Russell Mapes et al.|Blood|2005Cited by 11
A Multicenter Phase II Study of Combination Treatment with Melphalan, Arsenic Trioxide and Vitamin C (MAC) for Patients with Relapsed or Refractory Multiple Myeloma.James R. Berenson, Sal Bevivino, Ralph V. Boccia et al.|Blood|2005Cited by 5